Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study.
Saved in:
| Title: | Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study. |
|---|---|
| Authors: | Alemany A; ISGlobal, Barcelona, Spain.; Fight Infectious Diseases Foundation, Badalona, Spain.; Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Balanza N; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain., Millat-Martinez P; ISGlobal, Barcelona, Spain., Ouchi D; ISGlobal, Barcelona, Spain.; Fight Infectious Diseases Foundation, Badalona, Spain., Corbacho-Monné M; Fight Infectious Diseases Foundation, Badalona, Spain.; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Hospital Universitari Parc Taulí, Sabadell, Spain., Morales-Indiano C; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Clinical Laboratory Metropolitana Nord, Badalona, Spain., Fernández Rivas G; Microbiology Department, Clinical Laboratory Metropolitana Nord, Barcelona, Spain., Blanco I; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Clinical Laboratory Metropolitana Nord, Badalona, Spain., Mitjà O; Fight Infectious Diseases Foundation, Badalona, Spain.; Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Aguilar R; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Dobaño C; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Bassat Q; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain.; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; ICREA, Pg Lluís Companys 23, Barcelona, Spain.; Pediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Esplugues, Barcelona, Spain.; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique., Moncunill G; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Baro B; ISGlobal, Barcelona, Spain. |
| Corporate Authors: | COnV-ert BMK STUDY GROUP |
| Source: | Frontiers in immunology [Front Immunol] 2024 Nov 27; Vol. 15, pp. 1501872. Date of Electronic Publication: 2024 Nov 27 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2024.1501872 |
